INTERNATIONAL PATENT: AMPHISTA THERAPEUTICS LIMITED FILES APPLICATION FOR "TETRAHYDROISOQUINOLINE COMPOUNDS FOR TARGETED PROTEIN DEGRADATION"

GENEVA, March 17 -- AMPHISTA THERAPEUTICS LIMITED (The Cori Building, Granta ParkGreat AbingtonCambridge CB21 6GQ) filed a patent application (PCT/EP2025/075384) for "TETRAHYDROISOQUINOLINE COMPOUNDS FOR TARGETED PROTEIN DEGRADATION" on Sep 05, 2025. With publication no. WO/2026/052822, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROWN, Giles Albert (c/o Amphista Therapeutics LimitedThe Cori Building, Granta ParkGreat AbingtonCambridge CB21 6GQ), MCGARRY, David (c/o Amphista Therapeutics LimitedThe Cori Building, Gran...